Next generation particle accelerator diagnostics
The QUASAR Group has pioneered innovative beam diagnostics solutions for accelerators and light sources.
JetDose project set to optimise proton beam cancer therapy
The novel beam monitor will enable non-invasive in-vivo beam dosimetry in hadron beam cancer therapy.
Optical-fibre based machine protection system for particle accelerators
The QUASAR Group built upon existing research outcomes to develop and commercialise a new beam loss monitoring device.